ATHANASE INNOVATION AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.3 SEK | -0.61% |
|
+3.82% | -4.12% |
| Mar. 18 | Logistea AB Refinances Bank Loans of SEK 895 Million | CI |
| Feb. 23 | Athanase Innovation AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 2,980 | 738.8 | 429.2 |
| Enterprise Value (EV) 1 | 2,234 | 94.86 | -27.69 |
| P/E ratio | -112 x | -6.45 x | -9 x |
| Yield | - | - | - |
| Capitalization / Revenue | 739,637,611 x | -16,264,705 x | 10,572,169 x |
| EV / Revenue | 554,380,476 x | -2,088,340 x | -682,043 x |
| EV / EBITDA | -116,649,203 x | -825,418 x | 438,127 x |
| EV / FCF | -435 x | -1.85 x | 0.55 x |
| FCF Yield | -0.23% | -54.1% | 183% |
| Price to Book | 3.28 x | 0.93 x | 0.68 x |
| Nbr of stocks (in thousands) | 31,042 | 31,042 | 25,249 |
| Reference price 2 | 96.00 | 23.80 | 17.00 |
| Announcement Date | 4/20/22 | 2/24/23 | 2/23/24 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales | - | 4.029 | -45.42 | 40.6 |
| EBITDA | - | -19.15 | -114.9 | -63.2 |
| EBIT 1 | -0.375 | -30.6 | -130.4 | -77.73 |
| Operating Margin | - | -759.44% | 287.1% | -191.46% |
| Earnings before Tax (EBT) 1 | -2.108 | -30.34 | -123.6 | -67.22 |
| Net income 1 | -8.76 | -26.55 | -114.5 | -56.26 |
| Net margin | - | -658.97% | 252.14% | -138.58% |
| EPS 2 | -0.3609 | -0.8553 | -3.690 | -1.890 |
| Free Cash Flow 1 | 0.7721 | -5.132 | -51.35 | -50.65 |
| FCF margin | - | -127.36% | 113.05% | -124.76% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 4/20/22 | 4/20/22 | 2/24/23 | 2/23/24 |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | 0.47 | 746 | 644 | 457 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow 1 | 0.77 | -5.13 | -51.4 | -50.7 |
| ROE (net income / shareholders' equity) | -111% | -5.83% | -13.5% | -7.89% |
| ROA (Net income/ Total Assets) | -0.2% | -4.15% | -9.34% | -6.43% |
| Assets 1 | 4,404 | 640.4 | 1,227 | 874.6 |
| Book Value Per Share 2 | 0.1500 | 29.20 | 25.50 | 25.10 |
| Cash Flow per Share 2 | 0.0200 | 24.10 | 20.60 | 18.10 |
| Capex | - | 0.07 | - | - |
| Capex / Sales | - | 1.61% | - | - |
| Announcement Date | 4/20/22 | 4/20/22 | 2/24/23 | 2/23/24 |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -4.12% | 37.54M | |
| +36.16% | 27.94B | |
| -13.74% | 26.97B | |
| +25.00% | 26.95B | |
| -0.71% | 25.32B | |
| +44.49% | 22.58B | |
| +2.78% | 19.59B | |
| +1.45% | 19.52B | |
| +28.54% | 16.23B | |
| -14.80% | 14.98B |
- Stock Market
- Equities
- ATIN Stock
- Financials Athanase Innovation AB
